Current Practices and Challenges in the Diagnosis and Management of PKU in Latin America: A Multicenter Survey.
Soraia PoloniBruna Bento Dos SantosAna Elena ChiesaNorma SpecolaMarcela PereyraManuel Saborío-RocafortMaría Florencia SalazarMaría Jesús Leal-WittGabriela CastroFelipe PeñalozaSunling Palma WongRamsés Badilla PorrasLourdes Ortiz ParanzaMarta Cristina SanabriaMarcela Vela AmievaMarco MoralesAmanda Rocío Caro NaranjoAntonieta MahfoudAna Rosa ColmenaresAida LemesJosé Fernando Sotillo-LindoCeila PerezLaritza Martínez ReyGeorgina María Zayas TorrienteLilia Farret RefoscoIda Vanessa Doederlein SchwartzVeronica CornejoPublished in: Nutrients (2021)
This study aimed to describe the current practices in the diagnosis and dietary management of phenylketonuria (PKU) in Latin America, as well as the main barriers to treatment. We developed a 44-item online survey aimed at health professionals. After a pilot test, the final version was sent to 25 practitioners working with inborn errors of metabolism (IEM) in 14 countries. Our results include 22 centers in 13 countries. Most countries (12/13) screened newborns for PKU. Phenylalanine (Phe) targets at different ages were very heterogeneous among centers, with greater consistency at the 0-1 year age group (14/22 sought 120-240 µmol/L) and the lowest at >12 years (10 targets reported). Most countries had only unflavored powdered amino acid substitutes (10/13) and did not have low-protein foods (8/13). Only 3/13 countries had regional databases of the Phe content of foods, and only 4/22 centers had nutrient analysis software. The perceived obstacles to treatment were: low purchasing power (62%), limited/insufficient availability of low-protein foods (60%), poor adherence, and lack of technical resources to manage the diet (50% each). We observed a heterogeneous scenario in the dietary management of PKU, and most countries experienced a lack of dietary resources for both patients and health professionals.